Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$30,000.00

Regulation of Th17 cells by fibroblast microenvironment in the airways

EF 2011-12

Résumé
Cellular interactions between immune and structural cells play a key role in regulating the fate of the immune response. Recently, structural cells such as fibroblasts, endothelial cells and epithelial cells have been considered to play an important role in the resolution of the immune response. They are able to control the type and duration of leukocyte infiltrates in the tissue through specific chemokine gradients. Alteration of the phenotype of these cells and their environment may lead to chronic inflammation observed in different diseases such as arthritis and asthma. Immune cells are recruited to the site of the inflammation by chemokines. Since these chemokines are elaborated mainly by resident cells, a variety of autocrine/ paracrine networks could take place between structural and immune cells. T helper cells are one of major players in immune response regulation. Different T helper cells support unique effector functions via distinct cytokine expression profiles. Among these, Th17 cells are pro-inflammatory and are considered as the link by which the adaptive immune system communicates with the innate immune system. This subset is involved in several autoimmune diseases, including inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, and asthma. Th17 cells are a unique set of T helper cells characterized by the production of IL-17. IL-17 is known as a modulator of fibroblast function. This cytokine stimulates the production of IL-6, IL-11, IL-8 and CXCL1 by bronchial fibroblasts. Co-culture of fibroblasts with T cells increased IL-17 and CD40L expression by T cells. This increase of IL-17 and CD40L stimulated the production of CXCL12 (SDF1) a chemokine that promotes migration of CD4+ memory cells. All these data suggest that fibroblast microenvironment may participate to the induction and maintenance of Th17. Therefore, we postulate that bronchial fibroblasts constitute a favourable microenvironment to promote Th17 cells. These cells in turn activate bronchial fibroblasts to release chemokines that attract and maintain Th17 cells. The main goal of this application is to scrutinize the mechanism of interaction between fibroblasts and Th17 and its contribution to local mucosal immune response.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
401958-2011
Name nom
Chakir, Jamila
Department département
Médecine, Faculté de
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5204
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Immunology
Research subject fr
Immunologie
Partie
1
Nb partie
1
Application title
Regulation of Th17 cells by fibroblast microenvironment in the airways
Keyword
NSERC
Application summary
Cellular interactions between immune and structural cells play a key role in regulating the fate of the immune response. Recently, structural cells such as fibroblasts, endothelial cells and epithelial cells have been considered to play an important role in the resolution of the immune response. They are able to control the type and duration of leukocyte infiltrates in the tissue through specific chemokine gradients. Alteration of the phenotype of these cells and their environment may lead to chronic inflammation observed in different diseases such as arthritis and asthma. Immune cells are recruited to the site of the inflammation by chemokines. Since these chemokines are elaborated mainly by resident cells, a variety of autocrine/ paracrine networks could take place between structural and immune cells. T helper cells are one of major players in immune response regulation. Different T helper cells support unique effector functions via distinct cytokine expression profiles. Among these, Th17 cells are pro-inflammatory and are considered as the link by which the adaptive immune system communicates with the innate immune system. This subset is involved in several autoimmune diseases, including inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, and asthma. Th17 cells are a unique set of T helper cells characterized by the production of IL-17. IL-17 is known as a modulator of fibroblast function. This cytokine stimulates the production of IL-6, IL-11, IL-8 and CXCL1 by bronchial fibroblasts. Co-culture of fibroblasts with T cells increased IL-17 and CD40L expression by T cells. This increase of IL-17 and CD40L stimulated the production of CXCL12 (SDF1) a chemokine that promotes migration of CD4+ memory cells. All these data suggest that fibroblast microenvironment may participate to the induction and maintenance of Th17. Therefore, we postulate that bronchial fibroblasts constitute a favourable microenvironment to promote Th17 cells. These cells in turn activate bronchial fibroblasts to release chemokines that attract and maintain Th17 cells. The main goal of this application is to scrutinize the mechanism of interaction between fibroblasts and Th17 and its contribution to local mucosal immune response.